Electrophotographic photoconductors containing a bis-enamine compound
    1.
    发明授权
    Electrophotographic photoconductors containing a bis-enamine compound 失效
    含有双烯胺化合物的电子照相感光体

    公开(公告)号:US5389479A

    公开(公告)日:1995-02-14

    申请号:US110929

    申请日:1993-08-24

    摘要: The present invention provides a highly sensitive and highly durable electrophotographic photoconductor providing a conductive support and a photosensitive layer formed thereon, the photosensitive layer comprising a bis-enamine compound of the formula (I): ##STR1## wherein "A" is a C.sub.6-12 arylene group which may have a substituent, a bivalent heterocyclic reside which may have a substituent, a C.sub.2-4 lower alkylene group which may have a substituent; "B" is a lower dialkylamino group, a lower alkoxy group, a lower alkyl group, a hydrogen atom or a halogen atom; and k is an integer from 1 to 5 provided that when k is an integer of 2 or more, "B" may be identifcal or different, may together form a ring; and n is an integer from 2 to 4. The electrophotographic photoconductor according to this invention is excellent in stability resisting fluctuations in temperature and humidity, high in electric chargeability, almost free from reduction in photosensitivity in repetitive use and also free from deterioration in image quality such as defection in toner images.

    摘要翻译: 本发明提供了一种高灵敏度和高度耐用的电子照相感光体,其提供导电性支持体和形成在其上的感光层,感光层包含式(I)的双烯胺化合物:其中“A”为 可以具有取代基的C 6-12亚芳基,可以具有取代基的2价杂环,可以具有取代基的C2-4低级亚烷基; “B”为低级二烷基氨基,低级烷氧基,低级烷基,氢原子或卤素原子; 并且k是1至5的整数,条件是当k为2或更大的整数时,“B”可以是相同或不同的,可以一起形成环; n为2〜4的整数。本发明的电子照相感光体的耐温度和湿度的稳定性优异,电荷充电性高,重复使用时的感光度几乎不降低,且图像质量下降 例如墨粉图像中的缺陷。

    Trialkylamine derivative and ameliorant for digestive tract movement
containing the same
    2.
    发明授权
    Trialkylamine derivative and ameliorant for digestive tract movement containing the same 失效
    三烷基胺衍生物和含消化道运动的改善剂

    公开(公告)号:US5380748A

    公开(公告)日:1995-01-10

    申请号:US107825

    申请日:1993-08-30

    摘要: A trialkylamine derivative represented by the formula (1) or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different from each other and each represents lower alkyl;R.sup.3, R.sup.4 and R.sup.5 may be the same or different from one another and each represents hydrogen, lower alkyl, lower alkoxy, lower alkoxycarbonyl or halogen;R.sup.6 and R.sup.7 may be the same or different from each other and each represents hydrogen or lower alkyl;R.sup.8 represents hydrogen, lower alkyl, lower alkoxy or halogen;X represents oxygen, sulfur, --CH.dbd.N-- or --CH.dbd.CH--;Y represents oxygen, sulfur, methylene, N--R.sup.11 (wherein R.sup.11 represents lower alkyl), SO or SO.sub.2 ;Z represents --OCO(CH.sub.2).sub.p .about. or --OCH.sub.2 (CH.sub.2).sub.p .about. (wherein p represents a number of 0 to 4 and symbol .about. represents the linkage with a benzene ring); andm and n represent each a number of 0 to 3 and the sum of m and n is 3 or less, provided that the case where m is 0, n is 1 or 2, R.sup.1 and R.sup.2 represent each methyl, X represents --CH.dbd.CH--, Y represents --CH.sub.2 --, and Z represents --O--CO.about. is excluded. These compounds have an excellent activity of ameliorating for gastrointestinal motility and hence are widely utilized in the treatment of gastrointestinal diseases.

    摘要翻译: PCT No.PCT / JP92 / 00270 Sec。 371日期:1993年8月30日 102(e)日期1993年8月30日PCT 1991年3月6日PCT公布。 出版物WO92 / 15553 日本9月17日,1992.由式(1)表示的三烷基胺衍生物或其药学上可接受的盐:其中R 1和R 2可以相同或不同,各自表示低级烷基; R 3,R 4和R 5可以彼此相同或不同,并且各自表示氢,低级烷基,低级烷氧基,低级烷氧基羰基或卤素; R 6和R 7可以相同或不同,各自表示氢或低级烷基; R8代表氢,低级烷基,低级烷氧基或卤素; X表示氧,硫,-CH = N-或-CH = CH-; Y表示氧,硫,亚甲基,N-R11(其中R11表示低级烷基),SO或SO2; Z表示-OCO(CH 2)p DIFFERENCE或-OCH 2(CH 2)p差异(其中p表示0至4的数字,符号DIFFERENCE表示与苯环的连接); m和n分别表示0〜3的数,m与n的和为3以下,m为0,n为1或2的情况下,R 1,R 2表示甲基,X表示-CH = CH-,Y表示-CH 2 - ,Z表示-O-CO不同。 这些化合物具有改善胃肠蠕动的优异活性,因此被广泛用于治疗胃肠道疾病。

    Aromatic carboxamides
    3.
    发明授权
    Aromatic carboxamides 失效
    芳香族甲酰胺

    公开(公告)号:US5216153A

    公开(公告)日:1993-06-01

    申请号:US852607

    申请日:1992-03-17

    摘要: Compounds of the general formula ##STR1## wherein R.sup.1 is hydrogen, halogen or OR.sup.5 ; R.sup.2 is hydrogen, lower-alkyl lower-alkoxy or halogen; R.sup.3 and R.sup.4 each independently are lower-alkyl or taken together are alkylene with 3-5 C atoms in a straight-chain; R.sup.5 is hydrogen, acyl, lower-alkoxycarbonyl, lower-alkyl, amino-lower-alkyl, mono-alkylamino-lower-alkyl di-alkylamino-lower-alkyl or a N-containing 5-8-membered saturated or unsaturated monocyclic heterocyclic ring which is attached via a N atom to lower alkyl; and M signifies --CONH-- or --NHCO--, which can be used as medicaments, e.g., for the treatment of neoplasms and dermatological indications of an inflammatory and allergic nature.

    摘要翻译: 通式为其中R 1为氢,卤素或OR 5的通式为其的化合物; R2是氢,低级烷基低级烷氧基或卤素; R3和R4各自独立地为低级烷基或一起为直链中具有3-5个C原子的亚烷基; R5是氢,酰基,低级烷氧基羰基,低级烷基,氨基 - 低级 - 烷基,单烷基氨基 - 低级 - 烷基二 - 烷基氨基 - 低级烷基或含N的5-8元饱和或不饱和单环杂环 其通过N原子连接到低级烷基; 并且M表示-CONH-或-NHCO-,其可以用作药物,例如用于治疗炎性和过敏性质的赘生物和皮肤病学适应症。

    Carboxyimidamide derivatives
    4.
    发明授权
    Carboxyimidamide derivatives 失效
    羧甲酰胺衍生物

    公开(公告)号:US4499105A

    公开(公告)日:1985-02-12

    申请号:US452194

    申请日:1982-12-28

    申请人: Harm J. Panneman

    发明人: Harm J. Panneman

    摘要: The present invention is dealing with compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, in which n and m represent the number 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NR.sub.x R.sub.y, in which R.sub.x and R.sub.y represent hydrogen, alkyl (1-4 C) or a sulphonyl group and R represents the group ##STR2## in which R.sub.1 and R.sub.2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono or dialkyl (1-4 C) amino, having potent platelet aggregation inhibiting properties.

    摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐,其中n和m代表数字1或2,X和Y氢,烷基(1-4C),烷氧基(1-4 (1-4C),酰氧基(1-4C)或NRxRy,其中Rx和Ry代表氢,烷基(1-4C)或磺酰基(1-4C),羟基,卤素,羟甲基, 基团,R表示其中R1和R2表示氢,烷基(1-4C),羟基,烷氧基(1-4C),苯基烷氧基(7-10C),酰氧基,氨基或单或二烷基 (1-4C)氨基,具有有效的血小板聚集抑制性质。

    Bicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl
transferase
    10.
    发明授权
    Bicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl transferase 失效
    作为酰基辅酶A:胆固醇酰基转移酶的抑制剂的双环酰胺

    公开(公告)号:US5416118A

    公开(公告)日:1995-05-16

    申请号:US122537

    申请日:1993-09-28

    摘要: Novel bicyclic amides of the formula ##STR1## wherein Ar.sup.1 and Ar.sup.2 are phenyl, R.sup.2 -substituted phenyl, heteroaryl or R.sup.2 -substituted heteroaryl, wherein R.sup.2 is 1 to 3 substituents independently selected from the group consisting of halogeno, hydroxy, lower alkyl, lower alkoxy, nitro, amino, lower alkylamino and lower dialkylamino;X, Y and Z are --CH.sub.2 --, --CH(alkyl)--, --C(alkyl).sub.2 --, --NH--, --N(alkyl)--, --O-- or --SO.sub.r, wherein r is 0, 1 or 2, and m, n and p are 0 or 1;R.sup.1 is an alkyl chain of 1 to 25 carbon atoms; an alkyl chain substituted by one or more optionally substituted phenyl or heteroaryl groups; an alkyl chain --O--, --SO.sub.r, phenylene, R.sup.2 -substituted phenylene, heteroarylene or R.sup.2 -substituted heteroarylene groups; an interrupted alkyl chain substituted by one or more optionally substituted phenyl or heteroaryl groups; an alkyl chain of 4 to 25 carbon atoms, interrupted by one or more --NH--, --C(O)-- or --N(lower alkyl)-- groups; an interrupted alkyl chain of 4 to 25 carbon atoms substituted by one or more phenyl, R.sup.2 -substituted phenyl, heteroaryl or R.sup.2 -substituted heteroaryl groups; a diphenylamino group; a di-(R.sup.2 -substituted phenyl)amino group; a diheteroarylamino group; or a di-(R.sup.2 -substituted heteroaryl)amino group;or a pharmaceutically acceptable salt thereof, useful in the treatment of artherosclerosis are disclosed.

    摘要翻译: PCT No.PCT / US92 / 02662 Sec。 371日期:1993年9月28日 102(e)日期1993年9月28日PCT提交1992年4月9日PCT公布。 第WO92 / 18462号公报 日期:1992年10月29日。式IMA IMA的新型双环酰胺其中Ar 1和Ar 2是苯基,R 2取代的苯基,杂芳基或R 2取代的杂芳基,其中R 2是1至3个独立地选自卤代 ,羟基,低级烷基,低级烷氧基,硝基,氨基,低级烷基氨基和低级二烷基氨基; X,Y和Z是-CH 2 - , - CH(烷基) - , - C(烷基)2 - , - NH - , - N(烷基) - , - O-或-SOr,其中r是0,1或 2,m,n和p为0或1; R1是1〜25个碳原子的烷基链; 被一个或多个任选取代的苯基或杂芳基取代的烷基链; 烷基链-O-,-SOr,亚苯基,R 2取代的亚苯基,亚杂芳基或R 2取代的亚杂芳基; 被一个或多个任选取代的苯基或杂芳基取代的间断烷基链; 4个至25个碳原子的烷基链,被一个或多个-NH-,-C(O) - 或-N(低级烷基)基团间隔; 被一个或多个苯基,R 2取代的苯基,杂芳基或R 2取代的杂芳基取代的具有4至25个碳原子的中断的烷基链; 二苯基氨基; 二(R 2取代苯基)氨基; 二杂芳基氨基; 或二(R 2取代的杂芳基)氨基; 或其药学上可接受的盐,其可用于治疗动脉粥样硬化。